On August 7 2026, Matthew Rabinowitz, Executive Chairman and Director of Natera, Inc. (NASDAQ: NTRA), sold 2,000 shares of Natera common stock under a Rule 10b5‑1 trading plan that he adopted on December 5 2025. The shares were sold at $320.9 per share, generating gross proceeds of $641,800. At the time of the transaction the stock was trading near its 52‑week high of $323, reflecting a 112 % total return over the prior twelve months, although InvestingPro analysts consider the price overvalued relative to their fair‑value estimate and note that the company has remained unprofitable for the last twelve months with no profitability expected this year. Natera’s market capitalization stands at $38.1 billion and the firm reported revenue growth of 38 % over the trailing twelve‑month period. Following the sale, Rabinowitz’s direct holding in Natera amounted to 2,275,394 shares, and an additional 2,000 shares are indirectly beneficially owned by his spouse. In its most recent quarterly update, Natera announced second‑quarter revenue of approximately $753 million, comfortably exceeding Wall Street’s consensus forecast of $661.26 million. The company attributed the outperformance to accelerated performance across its core business segments, record test volume, improved margins and several regulatory achievements, and consequently raised its full‑year revenue guidance. The insider transaction and the strong quarterly results together position Natera prominently among investors and analysts.